SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Stock Picking for Charity - 2007 -- Ignore unavailable to you. Want to Upgrade?


To: keokalani'nui who wrote (87)1/2/2007 12:49:11 PM
From: BulbaMan  Respond to of 397
 
Wilder: Since Yahoo quotes Acambis' LSE price, it's not a problem for me. To be consistent, I'll use the 12/29/06 closing pound exchange rate of $1.9587, which gives you a few more shares. Also, as with everyone else, I adjusted all your share totals, using fractional shares, so the portfolio total adds up to exactly $100,000.
Thanks for your pledge "in my honor." I'm holding off picking my charity for now but will hopefully pick one by year-end.



To: keokalani'nui who wrote (87)1/2/2007 5:16:02 PM
From: Rocky9  Read Replies (1) | Respond to of 397
 

ASPV 20% 20.53
BVF 20% 21.16
CBST 5% 18.11
MOGN 5% 18.41
NURO 5% 14.91
SEPR 5% 61.58
TRMS 20% 12.71
VPHM 20% 14.64


$100 - I will name a charity if I'm close.

Might explain the picks later.



To: keokalani'nui who wrote (87)1/30/2007 11:21:13 AM
From: dr.praveen  Read Replies (1) | Respond to of 397
 
Have noticed that the 300mg dose of Droxidopa showed stat sig at 3/day. 3/day is fine coz sinemet is thrice daily too. No safety concerns as I can see. Any thoughts about the 300mg dose (if they are going to increase it) and your market expectation? They are planning for a straight P3 right? Any thoughts on 1504 and it's formulation issues? Thx mucho